Skip to content
10-Q

Quarterly Report

TELA Bio, Inc. TELA

0001104659-26-060234

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 44.77M sh
Shares Diluted Q1 2026 · Mar 31, 2026 57.26M sh
Shares Diluted Q1 2026 · Mar 31, 2025 45.27M sh
Capex Q1 2026 · Mar 31, 2026 $119K
Capex Q1 2026 · Mar 31, 2025 $32K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$11.17M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$9.73M
Long Term Debt Q1 2026 · Mar 31, 2026 $55.87M
Long Term Debt Q1 2026 · Dec 31, 2025 $55.65M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $39.54M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $50.85M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $42.83M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$5.2M
Stockholders Equity Q1 2026 · Dec 31, 2025 $6.31M
Stockholders Equity Q1 2026 · Mar 31, 2025 $18.12M
Stockholders Equity Q1 2026 · Dec 31, 2024 $28.46M
Current Liabilities Q1 2026 · Mar 31, 2026 $17.83M
Current Liabilities Q1 2026 · Dec 31, 2025 $17.98M
Total Liabilities Q1 2026 · Mar 31, 2026 $75.09M
Total Liabilities Q1 2026 · Dec 31, 2025 $75.11M
Current Assets Q1 2026 · Mar 31, 2026 $64.3M
Current Assets Q1 2026 · Dec 31, 2025 $75.58M
Total Assets Q1 2026 · Mar 31, 2026 $69.89M
Total Assets Q1 2026 · Dec 31, 2025 $81.42M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.21
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.25
Eps Basic Q1 2026 · Mar 31, 2026 −$0.21
Eps Basic Q1 2026 · Mar 31, 2025 −$0.25
Sga Expense Q1 2026 · Mar 31, 2026 $4.17M
Sga Expense Q1 2026 · Mar 31, 2025 $3.84M
Rd Expense Q1 2026 · Mar 31, 2026 $2.34M
Rd Expense Q1 2026 · Mar 31, 2025 $2.54M
Net Income Q1 2026 · Mar 31, 2026 −$12.27M
Net Income Q1 2026 · Mar 31, 2025 −$11.26M
Operating Income Q1 2026 · Mar 31, 2026 −$10.53M
Operating Income Q1 2026 · Mar 31, 2025 −$10.47M
Gross Profit Q1 2026 · Mar 31, 2026 $12.52M
Gross Profit Q1 2026 · Mar 31, 2025 $12.51M
Revenue Q1 2026 · Mar 31, 2026 $19.06M
Revenue Q1 2026 · Mar 31, 2025 $18.52M